Arterial calcification and stiffness in chronic kidney disease

P G Kerr1, A P Guerin

  • 1Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia. peter.kerr@med.monash.edu.au

Insights

Patients with chronic kidney disease (CKD) experience significant vascular disease, primarily medial calcification. This review explores causes, assessment methods like pulse wave velocity, and potential treatments for arterial stiffness in CKD.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Vascular Biology

Background:

  • Chronic kidney disease (CKD) patients exhibit a high prevalence of vascular disease, characterized by medial calcification.
  • Traditional cardiovascular risk factors do not fully account for the elevated cardiovascular event rates in this population.
  • Medial calcification and arterial stiffness are key pathological features in CKD.

Purpose of the Study:

  • To review the problem of medial calcification and arterial stiffness in CKD patients.
  • To explore the evidence for their existence and potential pathological processes.
  • To discuss assessment techniques and potential interventions.

Main Methods:

  • Literature review focusing on medial calcification and arterial stiffness in CKD.
  • Examination of emerging factors (fetuin-A, MGP, OPN, FGF-23) and calcium-phosphate balance.
  • Discussion of pulse wave velocity (PWV) as an assessment tool.

Main Results:

  • CKD is associated with unusual medial calcification and arterial stiffness.
  • Several factors, including calcium and phosphate dysregulation, contribute to vascular pathology.
  • Pulse wave velocity is a valuable tool for assessing arterial stiffness in CKD.

Conclusions:

  • The etiology of medial calcification and arterial stiffness in CKD is multifactorial, involving factors beyond traditional risk factors.
  • Further research is needed to elucidate the roles of specific proteins and to develop effective interventions.
  • Current treatment strategies for reducing or reversing arterial calcification and stiffness in CKD are not yet definitive.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...